RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer

Abstract Background RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the si...

Full description

Bibliographic Details
Main Authors: Xi Sun, Yue Hu, Jing Wu, Liang Shi, Lei Zhu, Pei-Wen Xi, Ji-Fu Wei, Qiang Ding
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
P21
Online Access:http://link.springer.com/article/10.1186/s13046-018-0968-z
id doaj-29f762950ec54e8490f5b86db8634475
record_format Article
spelling doaj-29f762950ec54e8490f5b86db86344752020-11-25T01:30:03ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662018-12-0137111410.1186/s13046-018-0968-zRBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancerXi Sun0Yue Hu1Jing Wu2Liang Shi3Lei Zhu4Pei-Wen Xi5Ji-Fu Wei6Qiang Ding7Jiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityResearch Division of Clinical Pharmacology, the First Affiliated Hospital with Nanjing Medical UniversityJiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical UniversityAbstract Background RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the similar function in RNA processing and RBMS2 is a member of them. P21, also named CDKN1A, promotes cell cycle arrest and plays an important role in halting cell proliferation. In our study, we identified RBMS2 as a tumor suppressor in breast cancer. It inhibited the proliferation of breast cancer by positively regulating the stability of P21 mRNA in posttranscriptional way. Methods TCGA was used to identify differentially expressed RBPs in breast cancer. The effect of RBMS2 on breast cancer proliferation was evaluated in vitro using CCK-8 assays, colony formation assays and cell-cycle assays and the in vivo effect was investigated using a mouse tumorigenicity model. The main pathway and genes regulated by RBMS2 was detected by RNA sequencing. The RNA immunoprecipitation combined with dual-luciferase reporter assay were conducted to testify the direct binding between RBMS2 and P21. Rescue assay was used to detect P21 as the main target of RBMS2. Results The expression of RBMS2 was lower in breast cancer compared with normal tissues and was a favorable biomarker in breast cancer. RBMS2 inhibited the proliferation of breast cancer and P21 was the main target of RBMS2. RBMS2 stabilized the mRNA of P21 by directly binding to the AU-rich element of 3′-UTR region. Anti-proliferation activity induced by overexpression of RBMS2 was rescued by interfering with the expression of P21. Conclusion In conclusion, RBMS2 acted as a tumor suppressor in breast cancer and positively regulated the expression of P21 by stabilizing its mRNA.http://link.springer.com/article/10.1186/s13046-018-0968-zBreast cancerRBMS2P21Tumor suppressor
collection DOAJ
language English
format Article
sources DOAJ
author Xi Sun
Yue Hu
Jing Wu
Liang Shi
Lei Zhu
Pei-Wen Xi
Ji-Fu Wei
Qiang Ding
spellingShingle Xi Sun
Yue Hu
Jing Wu
Liang Shi
Lei Zhu
Pei-Wen Xi
Ji-Fu Wei
Qiang Ding
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
Journal of Experimental & Clinical Cancer Research
Breast cancer
RBMS2
P21
Tumor suppressor
author_facet Xi Sun
Yue Hu
Jing Wu
Liang Shi
Lei Zhu
Pei-Wen Xi
Ji-Fu Wei
Qiang Ding
author_sort Xi Sun
title RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_short RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_full RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_fullStr RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_full_unstemmed RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_sort rbms2 inhibits the proliferation by stabilizing p21 mrna in breast cancer
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2018-12-01
description Abstract Background RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the similar function in RNA processing and RBMS2 is a member of them. P21, also named CDKN1A, promotes cell cycle arrest and plays an important role in halting cell proliferation. In our study, we identified RBMS2 as a tumor suppressor in breast cancer. It inhibited the proliferation of breast cancer by positively regulating the stability of P21 mRNA in posttranscriptional way. Methods TCGA was used to identify differentially expressed RBPs in breast cancer. The effect of RBMS2 on breast cancer proliferation was evaluated in vitro using CCK-8 assays, colony formation assays and cell-cycle assays and the in vivo effect was investigated using a mouse tumorigenicity model. The main pathway and genes regulated by RBMS2 was detected by RNA sequencing. The RNA immunoprecipitation combined with dual-luciferase reporter assay were conducted to testify the direct binding between RBMS2 and P21. Rescue assay was used to detect P21 as the main target of RBMS2. Results The expression of RBMS2 was lower in breast cancer compared with normal tissues and was a favorable biomarker in breast cancer. RBMS2 inhibited the proliferation of breast cancer and P21 was the main target of RBMS2. RBMS2 stabilized the mRNA of P21 by directly binding to the AU-rich element of 3′-UTR region. Anti-proliferation activity induced by overexpression of RBMS2 was rescued by interfering with the expression of P21. Conclusion In conclusion, RBMS2 acted as a tumor suppressor in breast cancer and positively regulated the expression of P21 by stabilizing its mRNA.
topic Breast cancer
RBMS2
P21
Tumor suppressor
url http://link.springer.com/article/10.1186/s13046-018-0968-z
work_keys_str_mv AT xisun rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT yuehu rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT jingwu rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT liangshi rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT leizhu rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT peiwenxi rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT jifuwei rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT qiangding rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
_version_ 1725093940172947456